Major Study Confirms Effectiveness & Safety of Tibetan Remedy for Vascular Pain

Exciting news in the nutraceutical world from EcoNugenics. A meta analysis of 19 studies concluded that Padma Basic, a Tibetan blend of herbs,is effective and safe in treating Perpheral Arterial Disease (PAD).

Santa Rosa, CA (PRWEB) June 15, 2006 -- EcoNugenics, a dietary supplement company announced today that a recent meta-analysis of 19 published studies and clinical trials determined that a Tibetan herbal product, called Padma Basic is safe and effective in providing significant relief for Peripheral Arterial Disease (PAD),is a serious condition that causes vascular pain in the legs and can lead to grave consequences, if left untreated. The meta-analysis was conducted on 2084 patients with PAOD and published in the May issue of Atherosclerosis, the International Journal for Research and Investigation and Related Diseases, the official journal of the European Atherosclerosis Society. Current FDA approved drugs have shown some limited benefit to treating PAD, but often the side effects make such treatments undesirable.

“This is excellent news for PAD patients and their physicians,” said Mark Blumenthal, founder and Executive Director of the nonprofit American Botanical Council. “This meta-analysis provides significant evidence of the safety and benefits of Padma Basic for PAD patients. Further, it provides added documentation that a multi-herb combination formula can meet the rigors of scientific testing to show beneficial activity for a serious medical condition.”

Up to eighteen million Americans have been diagnosed with PAD, but according to the research done by The Sage Group, it is estimated that there may be as many as 90 million Americans who suffer from this condition. Many people feel it when they are walking, a distinct pain or cramping in the calf. The pain comes and goes – and it’s often ignored or chalked up to getting older. Medical experts are in agreement that it needs to get checked out, because it could be PAD.

Similar to blocked blood vessels in the heart or brain that lead to heart disease or a stroke, blockages from atherosclerotic plaque that occur in the legs, left untreated, can cause many problems up to and including amputation and death. “PAD is vastly underappreciated, despite its alarming mortality rates,” said Isaac Eliaz, M.D. and founder of EcoNugenics.

About Padma Basic (Padma 28)

Padma Basic® is a highly researched herbal supplement consisting of 18 dried and milled herbs and spices, together with natural camphor and calcium sulfate. These ingredients are naturally rich in antioxidant substances supporting healthy circulation* and general immune health. In the Tibetan tradition, health and wellness maintain the body’s equilibrium. Circumstances such as diet, lifestyle, stress, and seasonal conditions can disturb this balance. The carefully chosen combination of herbs in Padma Basic supports the body’s natural function’s to help maintain good health and balance*. Padma Basic® is derived from an all natural traditional Tibetan herbal formula that has been used for centuries. Clinical studies now confirm the health supportive benefits of this formula along with proper diet and exercise, to gently restore balance.

EcoNugenics®, www.econugenics.com, was founded in 1995 upon a commitment to offer premium dietary supplements and nutraceuticals based on the best of modern science™ integrated with the ancient wisdom™ of traditional and complementary therapies. EcoNugenics® is committed to five basic principles, innovation in product formulation, scientific research, ongoing clinical validation, customer education, & empowerment and superior quality control.

Please note that Padma Basic® in not approved by the FDA for treatment of any disease and if you have a disease or health concern you should consult your health care professional before using Padma Basic® or any nutritional supplement.

###


Contact Information
Constance St. John
THE ST. JOHN GROUP
http://www.econugenics.com
415-454-2243

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy